Clinical role of the renal transplant biopsy

Nature Reviews Nephrology

Volumn 8, Issue 2, 2012, Pages 110-121

  Williams, Winfred W ^a   Taheri, Diana ^a   Tolkoff Rubin, Nina ^a   Colvin, Robert B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ACUTE TUBULAR INJURY; BIOINFORMATICS; CLINICAL PROTOCOL; DELAYED GRAFT FUNCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENE EXPRESSION; GLOMERULOSCLEROSIS; HUMAN; HYALINE DEGENERATION; KIDNEY ALLOGRAFT BIOPSY; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; RENAL GRAFT DYSFUNCTION; REVIEW; TREATMENT INDICATION;

BIOPSY, NEEDLE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 84856508567     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2011.213     Document Type: Review

References (101)

1. Colvin, R. B. et al. Diagnostic Pathology: Kidney Diseases (Amirsys, Salt Lake City, 2011).
2. Colvin, R. B. & Nickeleit, V. in Heptinstall's Pathology of the Kidney, Vol. 2 (eds Jennette, J. C., Olson, J. L., Schwartz, M. M. & Silva, F. G.) 1347-1490 (Lippincott-Raven, Philadelphia, 2006).
3. Pascual, M. et al. The clinical usefulness of the renal allograft biopsy in the cyclosporine era: a prospective study. Transplantation 67, 737-741 (1999). (Pubitemid 29161716)
4. Nickeleit, V. Pathology: donor biopsy evaluation at time of renal grafting. Nat. Rev. Nephrol. 5, 249-251 (2009).
5. Massie, A. B., Desai, N. M., Montgomery R. A., Singer, A. L. & Segev, D. L. Improving distribution efficiency of hard-to-place deceased donor kidneys: predicting probability of discard or delay. Am. J. Transplant. 10, 1613-1620 (2010).
6. Remuzzi, G. et al. Long-term outcome of renal transplantation from older donors. N. Engl. J. Med. 354, 343-352 (2006). (Pubitemid 43145059)
7. Munivenkatappa, R. B. et al. The Maryland aggregate pathology index: a deceased donor kidney biopsy scoring system for predicting graft failure. Am. J. Transplant. 8, 2316-2324 (2008).
8. Perco, P. et al. Histogenomics: association of gene expression patterns with histological parameters in kidney biopsies. Transplantation 87, 290-295 (2009).
9. Naesens, M. et al. Expression of complement components differs between kidney allografts from living and deceased donors. J. Am. Soc. Nephrol. 20, 1839-1851 (2009).
10. Kaminska, D. et al. Cytokine gene expression in kidney allograft biopsies after donor brain death and ischemia-reperfusion injury using in situ reverse-transcription polymerase chain reaction analysis. Transplantation 84, 1118-1124 (2007). (Pubitemid 350125353)
11. Mueller, T. F. et al. The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function. Am. J. Transplant. 8, 78-85 (2008).
12. Mas, V. R. et al. Distinctive gene expression profiles characterize donor biopsies from HCV-positive kidney donors. Transplantation 90, 1172-1179 (2010).
13. Kainz, A. et al. Gene-expression profiles and age of donor kidney biopsies obtained before transplantation distinguish medium term graft function. Transplantation 83, 1048-1054 (2007). (Pubitemid 46659116)
14. Kurian, S. M. et al. Laparoscopic donor nephrectomy gene expression profiling reveals upregulation of stress and ischemia associated genes compared to control kidneys. Transplantation 80, 1067-1071 (2005). (Pubitemid 41611929)
15. Schroppel, B. et al. Tubular expression of KIM-1 does not predict delayed function after transplantation. J. Am. Soc. Nephrol. 21, 536-542 (2010).
16. Reeves-Daniel, A. M. et al. The APOL1 gene and allograft survival after kidney transplantation. Am. J. Transplant. 11, 1025-1030 (2011).
17. Chapman, J. R. Longitudinal analysis of chronic allograft nephropathy: clinicopathologic correlations. Kidney Int. Suppl. 99, S108-S112 (2005).
18. Solez, K. et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am. J. Transplant. 8, 753-760 (2008). (Pubitemid 351347767)
19. Padiyar, A. et al. Influence of African-American ethnicity on acute rejection after early steroid withdrawal in primary kidney transplant recipients. Transplant. Proc. 42, 1643-1647 (2010).
20. Grafft, C. A. et al. Antibody-mediated rejection following transplantation from an HLA-identical sibling. Nephrol. Dial. Transplant. 25, 307-310 (2010).
21. Collins, A. B. et al. Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allografts. Transplant. Proc. 38, 3427-3429 (2006). (Pubitemid 44908535)
22. Haas, M. C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival. Clin. Nephrol. 75, 271-278 (2011).
23. Loupy, A. et al. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am. J. Transplant. 11, 56-65 (2011).
24. Seemayer, C. A., Gaspert, A., Nickeleit, V. & Mihatsch, M. J. C4d staining of renal allograft biopsies: a comparative analysis of different staining techniques. Nephrol. Dial. Transplant. 22, 568-576 (2007). (Pubitemid 46189903)
25. Noris, M. & Remuzzi, G. Thrombotic microangiopathy after kidney transplantation. Am. J. Transplant. 10, 1517-1523 (2010).
26. Satoskar, A. A. et al. De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection. Am. J. Transplant. 10, 1804-1811 (2010).
27. Briganti, E. M., Russ, G. R., McNeil, J. J., Atkins, R. C. & Chadban, S. J. Risk of renal allograft loss from recurrent glomerulonephritis. N. Engl. J. Med. 347, 103-109 (2002). (Pubitemid 34753480)
28. Hariharan, S. et al. Recurrent and de novo glomerular disease after renal transplantation: a report from the Renal Allograft Disease Registry (RADR). Transplantation 68, 635-641 (1999). (Pubitemid 29453439)
29. Angelo, J. R., Bell, C. S. & Braun, M. C. Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis. Am. J. Kidney Dis. 57, 291-299 (2011).
30. Wei, C. et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat. Med. 17, 952-960 (2011).
31. Qin, W. et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy patients. J. Am. Soc. Nephrol. http://dx.doi.org/10.1681/ASN. 2010090967.
32. Beck, L. H. Jr et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N. Engl. J. Med. 361, 11-21 (2009).
33. Randhawa, P. & Brennan, D. C. BK virus infection in transplant recipients: an overview and update. Am. J. Transplant. 6, 2000-2005 (2006). (Pubitemid 44199534)
34. Drachenberg, C. B. et al. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation 84, 323-330 (2007). (Pubitemid 47258319)
35. Nickeleit V, S. J. & Mihatsch, M. J. BK virus infection after kidney transplantation. Graft 5 (Suppl.), S46-S57 (2002). (Pubitemid 35446895)
36. Bracamonte, E. et al. Tubular basement membrane immune deposits in association with BK polyomavirus nephropathy. Am. J. Transplant. 7, 1552-1560 (2007). (Pubitemid 46776246)
37. Sar, A. et al. Interobserver agreement for polyomavirus nephropathy grading in renal allografts using the working proposal from the 10th Banff Conference on Allograft Pathology. Hum. Pathol. 42, 2018-2024 (2011).
38. Hirsch, H. H. et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N. Engl. J. Med. 347, 488-496 (2002). (Pubitemid 34879336)
39. Singh, H. K. et al. Presence of urinary Haufen accurately predicts polyomavirus nephropathy. J. Am. Soc. Nephrol. 20, 416-427 (2009).
40. Han Lee, E. D. et al. A mouse model for polyomavirus-associated nephropathy of kidney transplants. Am. J. Transplant. 6, 913-922 (2006). (Pubitemid 44356641)
41. Varma, M. C. et al. Early onset adenovirus infection after simultaneous kidney-pancreas transplant. Am. J. Transplant. 11, 623-627 (2011).
42. Storsley, L. & Gibson, I. W. Adenovirus interstitial nephritis and rejection in an allograft. J. Am. Soc. Nephrol. 22, 1423-1427 (2011).
43. Lamb, K. E., Lodhi, S. & Meier-Kriesche, H. U. Long-term renal allograft survival in the United States: a critical reappraisal. Am. J. Transplant. 11, 450-462 (2011).
44. Colvin, R. B. Chronic allograft nephropathy. N. Engl. J. Med. 349, 2288-2290 (2003). (Pubitemid 37509735)
45. Solez, K. et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am. J. Transplant. 7, 518-526 (2007). (Pubitemid 46376465)
46. El-Zoghby, Z. M. et al. Identifying specific causes of kidney allograft loss. Am. J. Transplant. 9, 527-535 (2009).
47. Mauiyyedi, S. et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J. Am. Soc. Nephrol. 12, 574-582 (2001). (Pubitemid 32180027)
48. Regele, H. et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J. Am. Soc. Nephrol. 13, 2371-2380 (2002). (Pubitemid 34925248)
49. Einecke G. et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am. J. Transplant. 9, 2520-2531 (2009).
50. Gaston, R. S. et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 90, 68-74 (2010).
51. Kieran, N. et al. Combination of peritubular c4d and transplant glomerulopathy predicts late renal allograft failure. J. Am. Soc. Nephrol. 20, 2260-2268 (2009).
52. Hill, G. S. et al. Donor specific antibodies accelerate arteriosclerosis after kidney transplantation. J. Am. Soc. Nephrol. 22, 975-983 (2011).
53. Sis, B. et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody mediated damage despite lack of C4d staining. Am. J. Transplant. 9, 2312-2323 (2009).
54. Hirohashi, T. et al. Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice. Am. J. Transplant. 10, 510-517 (2010).
55. Hirohashi, T. et al. A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am. J. Transplant. doi:10.1111/j.1600- 6143.2011.03836.x).
56. Hidalgo, L. G. et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am. J. Transplant. 10, 1812-1822 (2010).
57. Smith, R. N. et al. Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys. Am.J. Transplant. 8, 1662-1672 (2008).
58. Nickeleit, V., Zeiler, M., Gudat, F., Thiel, G. & Mihatsch, M. J. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J. Am. Soc. Nephrol. 13, 242-251 (2002). (Pubitemid 34042034)
59. Farris, A. B. et al. Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. Am. J. Transplant. 11, 1464-1477 (2011).
60. Nankivell, B. J. et al. The natural history of chronic allograft nephropathy. N. Engl. J. Med. 349, 2326-2333 (2003). (Pubitemid 37509740)
61. Snanoudj, R. et al. Specificity of histological markers of long-term CNI nephrotoxicity in kidney transplant recipients under low-dose cyclosporine therapy. Am. J. Transplant. 11, 2635-2646 (2011).
62. Chapman, J. R. Chronic calcineurin inhibitor nephrotoxicity-lest we forget. Am. J. Transplant. 11, 693-697 (2011).
63. Sis, B. et al. Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients. Am. J. Transplant. 6, 1444-1450 (2006). (Pubitemid 44030328)
64. Meehan, S. M. et al. De novo collapsing glomerulopathy in renal allografts. Transplantation 65, 1192-1197 (1998). (Pubitemid 28224337)
65. Dogan, E., Ghanta, M. & Tanriover, B. Collapsing glomerulopathy in a renal transplant recipient: potential molecular mechanisms. Ann. Transplant. 16, 113-116 (2011).
66. Baid-Agrawal, S. et al. Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy. Kidney Int. 80, 879-885 (2011).
67. Rubin, M. F. Hypertension following kidney transplantation. Adv. Chronic Kidney Dis. 18, 17-22 (2011).
68. Hurst, F. P. et al. Incidence, predictors and outcomes of transplant renal artery stenosis after kidney transplantation: analysis of USRDS. Am. J. Nephrol. 30, 459-467 (2009).
69. Mengel, M. et al. Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial. Am. J. Transplant. 5, 1050-1056 (2005). (Pubitemid 40571253)
70. Haas, M. et al. C4d and C3d staining in biopsies of ABO-and HLA-incompatible renal allografts: correlation with histologic findings. Am. J. Transplant. 6, 1829-1840 (2006). (Pubitemid 44024954)
71. Kraus, E. S. et al. Subclinical rejection in stable positive crossmatch kidney transplant patients: incidence and correlations. Am. J. Transplant. 9, 1826-1834 (2009).
72. Khamash, H. A. et al. Polyomavirus-associated nephropathy risk in kidney transplants: the influence of recipient age and donor gender. Kidney Int. 71, 1302-1309 (2007). (Pubitemid 46884257)
73. Seron, D. & Moreso, F. Protocol biopsies in renal transplantation: prognostic value of structural monitoring. Kidney Int. 72, 690-697 (2007). (Pubitemid 47373786)
74. Mengel, M. et al. Protocol biopsies in renal transplantation: insights into patient management and pathogenesis. Am. J. Transplant. 7, 512-517 (2007). (Pubitemid 46376459)
75. Lipman, M. L., Stevens, A. C. & Strom, T. B. Cytotoxic T lymphocyte (CTL) and immunosuppressive cytokine gene expression in human renal allograft biopsies. J. Am. Soc. Nephrol. 3, 867-872 (1992).
76. Nast, C. C. et al. ?-Interferon gene expression in human renal allograft fine-needle aspirates. Transplantation 57, 498-502 (1994). (Pubitemid 24075791)
77. Eikmans, M. et al. High transforming growth factor-β and extracellular matrix mRNA response in renal allografts during early acute rejection is associated with absence of chronic rejection. Transplantation 73, 573-579 (2002). (Pubitemid 34193618)
78. Sarwal, M. et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N. Engl. J. Med. 349, 125-138 (2003). (Pubitemid 36818782)
79. Hueso, M. et al. Intragraft expression of the IL-10 gene is up-regulated in renal protocol biopsies with early interstitial fibrosis, tubular atrophy, and subclinical rejection. Am. J. Pathol. 176, 1696-1704 (2010).
80. Einecke, G. et al. Expression of B cell and immunoglobulin transcripts is a feature of inflammation in late allografts. Am. J. Transplant. 8, 1434-1443 (2008). (Pubitemid 351989485)
81. Ashton-Chess, J. et al. Regulatory, effector, and cytotoxic T cell profiles in long-term kidney transplant patients. J. Am. Soc. Nephrol. 20, 1113-1122 (2009).
82. Homs, S. et al. Predominant TH1 and cytotoxic phenotype in biopsies from renal transplant recipients with transplant glomerulopathy. Am. J. Transplant. 9, 1230-1236 (2009).
83. Halloran, P. F. et al. The molecular phenotype of kidney transplants. Am. J. Transplant. 10, 2215-2222 (2010).
84. Isse, K. et al. Adding value to liver (and allograft) biopsy evaluation using a combination of multiplex quantum dot immunostaining, high-resolution whole-slide digital imaging, and automated image analysis. Clin. Liver Dis. 14, 669-685 (2010).
85. Park, W. D., Griffin, M. D., Cornell, L. D., Cosio, F. G. & Stegall, M. D. Fibrosis with inflammation at one year predicts transplant functional decline. J. Am. Soc. Nephrol. 21, 1987-1997 (2010).
86. Mueller, T. F. et al. Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am. J. Transplant. 7, 2712-2722 (2007). (Pubitemid 350045779)
87. Mengel, M., Sis, B. & Halloran, P. F. SWOT analysis of Banff: strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology. Am. J. Transplant. 7, 2221-2226 (2007). (Pubitemid 47347849)
88. Sis, B. et al. Cluster analysis of lesions in nonselected kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation and scarring. Am. J. Transplant. 10, 421-430 (2010).
89. Matas, A. et al. Histopathologic clusters differentiate subgroups within the nonspecific diagnoses of CAN or CR: preliminary data from the DeKAF study. Am. J. Transplant. 10, 315-323 (2010).
90. Servais, A. et al. Interstitial fibrosis quantification in renal transplant recipients randomized to continue cyclosporine or convert to sirolimus. Am. J. Transplant. 9, 2552-2560 (2009).
91. Farris, A. B. et al. Morphometric and visual evaluation of fibrosis in renal biopsies. J. Am. Soc. Nephrol. 22, 176-186 (2011).
92. Veronese, F. et al. Pathological and clinical correlates of FOXP3+ cells in renal allografts during acute rejection. Am. J. Transplant. 7, 914-922 (2007). (Pubitemid 46481190)
93. Bunnag, S. et al. FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am. J. Transplant. 8, 1423-1433 (2008). (Pubitemid 351989494)
94. Yapici, U. et al. Intragraft FOXP3 protein or mRNA during acute renal allograft rejection correlates with inflammation, fibrosis, and poor renal outcome. Transplantation 87, 1377-1380 (2009).
95. + cells. Am. J. Pathol. 178, 1635-1645 (2011).
96. + regulatory T cells predicts outcome of subclinical rejection of renal allografts. J. Am. Soc. Nephrol. 19, 2020-2026 (2008).
97. Mansour, H. et al. Intragraft levels of Foxp3 mRNA predict progression in renal transplants with borderline change. J. Am. Soc. Nephrol. 19, 2277-2281 (2008).
98. Grimbert, P. et al. The regulatory/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejection. Transplantation 83, 341-346 (2007).
99. + regulatory T cell recruitment in human renal allograft infiltrates. J. Immunol. 179, 4901-4909 (2007).
100. Muthukumar, T. et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N. Engl. J. Med. 353, 2342-2351 (2005). (Pubitemid 41713746)
101. Zhang, X. & Reed, E. F. Effect of antibodies on endothelium. Am. J. Transplant. 9, 2459-2465 (2009).